Diabetic neuropathy—the most common neuropathy in industrialized countries—encompasses a broad range of clinical manifestations. In this Review, Gérard Said discusses the clinical ...

The Diabetes Control and Complication Trial research group reported that clinical and electrophysiological evidence of neuropathy was reduced by 50% in those treated intensively with insulin. 46 ...

Diabetes mellitus is the most common cause of neuropathy worldwide. In this review, the clinical, pathological and therapeutic aspects of various forms of diabetic neuropathy are discussed.

Truncal Neuropathies. Truncal neuropathy is usually predominantly or completely unilateral. [32,33] The onset is abrupt or rapid, ... Multifocal Diabetic Neuropathy.

Zelira Therapeutics announced the publication of a clinical study demonstrating the efficacy and safety of its proprietary cannabinoid-based therapy, ZLT-L-007, in treating diabetic neuropathy.